Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
July 25, 2018
Single Step Determination of Unlabeled Compound Kinetics Using a Competition Association Binding Method Employing Time-Resolved FRET
David A Sykes, Steven J Charlton
British Journal of Pharmacology
|
September 3, 2011
Slow receptor dissociation is not a key factor in the duration of action of inhaled long-acting β2-adrenoceptor agonists
David A Sykes, Steven J Charlton
Molecular Pharmacology
|
August 23, 2019
Investigating the Influence of Tracer Kinetics on Competition-Kinetic Association Binding Assays: Identifying the Optimal Conditions for Assessing the Kinetics of Low-Affinity Compounds
David A Sykes, Palash Jain, Steven J Charlton
Molecular Pharmacology
|
June 6, 2009
Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M3 receptor
David A Sykes, Mark R Dowling, Steven J Charlton
Current Protocols in Pharmacology
|
February 2, 2012
Measuring receptor target coverage: a radioligand competition binding protocol for assessing the association and dissociation rates of unlabeled compounds
David A Sykes, Mark R Dowling, Steven J Charlton
Molecular and Cellular Endocrinology
|
February 11, 2019
Binding kinetics of ligands acting at GPCRs
David A Sykes, Leigh A Stoddart, Laura E Kilpatrick, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
March 1, 2020
GPCR Solubilization and Quality Control
Tamara Miljus, David A Sykes, Clare R Harwood, et al.
Molecular Pharmacology
|
January 31, 2014
Observed drug-receptor association rates are governed by membrane affinity: the importance of establishing "micro-pharmacokinetic/pharmacodynamic relationships" at the β2-adrenoceptor
David A Sykes, Cheryl Parry, John Reilly, et al.
Nature Communications
|
September 5, 2018
Reply to 'Antipsychotics with similar association kinetics at dopamine D<sub>2</sub> receptors differ in extrapyramidal side-effects'
David A Sykes, J Robert Lane, Monika Szabo, et al.
Pharmacology Research & Perspectives
|
June 28, 2022
Exploring the kinetic selectivity of drugs targeting the β<sub>1</sub> -adrenoceptor
David A Sykes, Mireia Jiménez-Rosés, John Reilly, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Methods in Molecular Biology (Clifton, N.J.)
|
July 25, 2018
Single Step Determination of Unlabeled Compound Kinetics Using a Competition Association Binding Method Employing Time-Resolved FRET
David A Sykes, Steven J Charlton
British Journal of Pharmacology
|
September 3, 2011
Slow receptor dissociation is not a key factor in the duration of action of inhaled long-acting β2-adrenoceptor agonists
David A Sykes, Steven J Charlton
Molecular Pharmacology
|
August 23, 2019
Investigating the Influence of Tracer Kinetics on Competition-Kinetic Association Binding Assays: Identifying the Optimal Conditions for Assessing the Kinetics of Low-Affinity Compounds
David A Sykes, Palash Jain, Steven J Charlton
Molecular Pharmacology
|
June 6, 2009
Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M3 receptor
David A Sykes, Mark R Dowling, Steven J Charlton
Current Protocols in Pharmacology
|
February 2, 2012
Measuring receptor target coverage: a radioligand competition binding protocol for assessing the association and dissociation rates of unlabeled compounds
David A Sykes, Mark R Dowling, Steven J Charlton
Molecular and Cellular Endocrinology
|
February 11, 2019
Binding kinetics of ligands acting at GPCRs
David A Sykes, Leigh A Stoddart, Laura E Kilpatrick, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
March 1, 2020
GPCR Solubilization and Quality Control
Tamara Miljus, David A Sykes, Clare R Harwood, et al.
Molecular Pharmacology
|
January 31, 2014
Observed drug-receptor association rates are governed by membrane affinity: the importance of establishing "micro-pharmacokinetic/pharmacodynamic relationships" at the β2-adrenoceptor
David A Sykes, Cheryl Parry, John Reilly, et al.
Nature Communications
|
September 5, 2018
Reply to 'Antipsychotics with similar association kinetics at dopamine D<sub>2</sub> receptors differ in extrapyramidal side-effects'
David A Sykes, J Robert Lane, Monika Szabo, et al.
Pharmacology Research & Perspectives
|
June 28, 2022
Exploring the kinetic selectivity of drugs targeting the β<sub>1</sub> -adrenoceptor
David A Sykes, Mireia Jiménez-Rosés, John Reilly, et al.
Page
of 5